1,000
Participants
Start Date
November 2, 2020
Primary Completion Date
August 31, 2050
Study Completion Date
August 31, 2050
Electroconvulsive Therapy (ECT)
ECT for the treatment of treatment-resistant depression OR Bipolar Disorder in an active major depressive episode
Transcranial Magnetic Stimulation (TMS)
TMS for the treatment of treatment-resistant depression in an active major depressive episode
Ketamine
Intravenous ketamine infusion for the treatment of treatment-resistant depression in an active major depressive episode
Esketamine
Intranasal esketamine insufflation for the treatment of treatment-resistant depression in an active major depressive episode
Deep Transcranial Magnetic Stimulation (dTMS)
TMS for the treatment of OCD
RECRUITING
University of Iowa Health Care, Iowa City
Mark Niciu
OTHER